Portfolio

PHM026 – C2 Portfolio of Evidence
Name: Matriculation number:
The portfolio must contain all the specified pieces of evidence below. Please ensure that you
understand exactly what is required and that you include all the required evidence in your
portfolio.
1. One reflective learning worksheet.
2. A list of identified learning resources.
3. Evidence of participation in Discussion Forums.
Further information can be found in the PHM026 Assessment Instructions on Moodle. Please
note that the portfolio must be all your own work.
Please ensure that you anonymise everything. Do not include any information which might
identify anyone: patients’ or colleagues’ names or initials, specific details of practice setting etc.
The completed portfolio should be submitted electronically via the drop box on Moodle by the
date indicated on the study calendar.
Save this file using the following format: Surname_Initial_Modulenumber_C2
(e.g.Gibson_T_PHM026_C2).
If you have any problems with this document please contact: [email protected]
Please ensure you read the How to use this document properly section (next page)
Version: 2021.1
How to use this document properly?
This document has been set up using headings so that you can “jump” to the pages of the
template you need with one click. Please follow the instructions below to turn the Navigation
panel on.
1. Click on the View tab

2. Click on the tick box next to Navigation Pane
1
3. The Navigation bar should appear on the

Left of your document. The headings
visible are links to the template
documents you need to complete
This navigation bar will now be available for

every word document you open.
Please note that the navigation panel will be

“on” on every word document you open from
now on.
If you have any further issues please do not

hesitate to contact Toni on [email protected]
Version: 2021.1
Reflective Learning Worksheet
(This mirrors the General Pharmaceutical Council’s form)
Please reflect on an aspect of your own learning within this module.
1 What are you planning to learn?
Describe what learning you are planning to carry out. What you need to learn
may be new knowledge, skills, or a new attitude or approach – anything that
you think will make you better able to do your job as a pharmacy professional
or prepare you for a new service or role. You should be as specific as possible.
You should explain why this learning is relevant to you in your role as a
pharmacy professional and how it will affect the people using your services. If
you don’t think it is relevant or will have a significant beneficial impact on
anyone, you might want to consider why you are planning to carry out and
record this learning.
Please take care not to disclose any confidential information about patients without their
consent.
How learning will affect patients

I am a technical services pharmacist that works as part of a team in delivering the chemotherapy
service at the Trust, I accuracy check chemotherapy medication and I am aware that there are
certain different procedures about it, but I don’t know why. I am planning to learn about
intrathecal chemotherapy and vinca alkaloids , the guidelines, and warnings around it. This will
affect the patients as I accuracy check and release chemotherapy medication for patients for the
nurses to administer to patients. There are different procedures are in place for intrathecal
chemotherapy and vinca alkaloids and how to administer it. If it isn’t prepared properly with the
most appropriate warnings it can affect patient safety and can result in death.
2 How are you planning to learn it?
It is important for you to consider a range of options for achieving your learning
across the breadth of your CPD entries. Focus your planned CPD on those
activities that are relevant to, or likely to have the biggest impact on, the
people using your services
I am going to attend a presentation on intrathecal chemotherapy, read about the NPSA alerts and
the alerts around chemotherapy. Furthermore, I will research the reasons as to why intrathecal
chemotherapy has different procedures to normal chemotherapy. I will read the trusts policies and
standard operating procedures about intrathecal chemotherapy and vinca alkaloids and how they
ensure patient safety with intrathecal chemotherapy.
Version: 2021.1
I am going to Watch a video on the harm caused by vinca alkaloids administered intrathecally and
the importance of ensuring procedures are in place to prevent these from happening again.
I am going to shadow fellow technical services pharmacists checking vinca alkaloids as well as
checking and releasing intrathecal chemotherapy. I will therefore be shadowed when checking
them and will only be signed off on this competency once I am competent and confident in doing
so.
3 Give an example of how this learning has benefitted the people

using your services?
Putting learning into practice is a good way to prove that you have actually
learnt what you intended. Tell us what specific skills, attitudes and/or
behaviours you have gained as a result of your learning.
Include a real example of how the people using your services have benefitted
from your learning. If you were able to introduce a new service successfully,
the benefits will be clear. If you are more confident in your ability to respond to
a particular query, or have some new knowledge that you can use in your
practice, that is also a beneficial outcome.
Do include any feedback about your practice that you have had from other
people.
How it has benefited people using an example

Intravenous chemotherapy given Intrathecally is a never event. Following the death and paralysis
of patients being administered a vinka alkaloid vincristine intrathecally, NPSA released alerts. These
were that Vinca alkaloids may only be administered intravenously and are almost always fatal
when administered intrathecally.
NPSA alert- All spinal (intrathecal) bolus doses and lumbar puncture samples are performed using
syringes, needles and other devices with safer connectors that will not connect with intravenous
Luer connectors.
I learnt about the policies and procedures of intrathecal chemotherapy that involved ensuring a
haematologist on the intrathecal register can only sign and request an intrathecal chemotherapy.
The labelling should be intrathecal use only and the medicine should be transported in a red
lockable box and transported separately from all other items. The pharmacist who releases the
intrathecal chemotherapy must be on the intrathecal register and the issue of it needs to be to the
haematologist that originally signed the prescription and is on the intrathecal chemotherapy. It
should be issued at different times to intravenous treatment and should only be administered by
the authorised haematologist on the intrathecal register.
Using this newfound knowledge, I have been able to teach other pharmacists as well as foundation
Version: 2021.1
pharmacists about the importance of intrathecal chemotherapy and ensuring its safety and making
sure procedures are followed. I have become confident in my knowledge and dealing with
intrathecal chemotherapy requests, knowing the guidelines and the reasons as to why they are the
way they are. The patients have benefited from this as we ensure the patients do not have
intravenous medication arranged at the same time as intrathecal chemotherapy and if they do, we
liaise to arrange at different times ensuring patient safety.
This increased knowledge has increased patient safety as it is putting procedures in place to
prevent any patient harm ensuring they get their chemotherapy in the safest way possible.
With vinca alkaloids, ensuring it has for IV use only fatal if given any other route written on the
label also putting them in yellow vinka alkaloid bags separately to ensure they are given iv.
Version: 2021.1
A list of identified learning
resources
These are the resources you have used in addition to the resources we provide you with
during this course
[Free text type here]
Version: 2021.1
Screenshots of post and
participation in discussion forums
You need to make at least THREE contributions (one post and at least two responses) in each assessed
discussion forum.
Import screenshots of your forum contributions by using the Insert tab, clicking on Picture and browse for
your pictures
Management, teamwork and leadership Assessment forum
[Insert here]
Patient safety: Managing medicines Assessment forum
[Insert here]
Version: 2021.1

Portfolio

Uploaded by

Copyright:

Available Formats

Portfolio

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Portfolio

Uploaded by

Copyright:

Available Formats

PHM026 – C2 Portfolio of Evidence

Name: Matriculation number:

1. One reflective learning worksheet.

2. A list of identified learning resources.

3. Evidence of participation in Discussion Forums.

note that the portfolio must be all your own work.

date indicated on the study calendar.

Save this file using the following format: Surname_Initial_Modulenumber_C2

1. Click on the View tab

3. The Navigation bar should appear on the

This navigation bar will now be available for

Please note that the navigation panel will be

If you have any further issues please do not

Please reflect on an aspect of your own learning within this module.

1 What are you planning to learn?

How learning will affect patients

2 How are you planning to learn it?

3 Give an example of how this learning has benefitted the people

How it has benefited people using an example

[Free text type here]

Management, teamwork and leadership Assessment forum

Patient safety: Managing medicines Assessment forum

You might also like